Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility StudyJohan Maertens, Johan Van Eldere, Koen Theunissen et al.|Clinical Infectious Diseases|2005Cited by 593
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validationJohan Maertens, Marc Boogaerts, Jan Verhaegen et al.|Blood|2001Cited by 514
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive AspergillosisJohan Maertens, Marc Boogaerts, Peter Vandenberghe et al.|Journal of Clinical Microbiology|1999Cited by 376
Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant RecipientsJohan Maertens, Marc Boogaerts, Johan Van Eldere et al.|The Journal of Infectious Diseases|2002Cited by 342
Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipientsJohan Maertens, Johan Van Eldere, Koen Theunissen et al.|British Journal of Haematology|2004Cited by 171